"Abortifacient Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances that interrupt pregnancy after implantation.
| Descriptor ID |
D000019
|
| MeSH Number(s) |
D27.505.696.875.131 D27.505.954.705.131
|
| Concept/Terms |
Abortifacient Agents- Abortifacient Agents
- Agents, Abortifacient
- Contraceptive Agents, Postconception
- Agents, Postconception Contraceptive
- Postconception Contraceptive Agents
- Abortifacients
Abortifacient Effect- Abortifacient Effect
- Effect, Abortifacient
- Abortifacient Effects
- Effects, Abortifacient
|
Below are MeSH descriptors whose meaning is more general than "Abortifacient Agents".
Below are MeSH descriptors whose meaning is more specific than "Abortifacient Agents".
This graph shows the total number of publications written about "Abortifacient Agents" by people in this website by year, and whether "Abortifacient Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Abortifacient Agents" by people in Profiles.
-
Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic. JAMA Netw Open. 2021 08 02; 4(8):e2122320.
-
Family medicine provision of online medication abortion in three US states during COVID-19. Contraception. 2021 07; 104(1):54-60.
-
"It was close enough, but it wasn't close enough": A qualitative exploration of the impact of direct-to-patient telemedicine abortion on access to abortion care. Contraception. 2021 07; 104(1):67-72.
-
Factors associated with successful implementation of telehealth abortion in 4 United States clinical practice settings. Contraception. 2021 07; 104(1):82-91.
-
Greasing the wheels: The impact of COVID-19 on US physician attitudes and practices regarding medication abortion. Contraception. 2021 09; 104(3):289-295.
-
Federal, state, and institutional barriers to the expansion of medication and telemedicine abortion services in Ohio, Kentucky, and West Virginia during the COVID-19 pandemic. Contraception. 2021 07; 104(1):111-116.
-
Changes to medication abortion clinical practices in response to the COVID-19 pandemic. Contraception. 2021 07; 104(1):77-81.
-
Attitudes of US adults toward using telemedicine to prescribe medication abortion during COVID-19: A mixed methods study. Contraception. 2021 07; 104(1):104-110.
-
Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models. Contraception. 2021 07; 104(1):49-53.
-
Changes in Abortion in Texas Following an Executive Order Ban During the Coronavirus Pandemic. JAMA. 2021 02 16; 325(7):691-693.